Velabs Therapeutics
About:
Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies.
Website: https://veraxa.de
Description:
Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies. Their high-throughput screening platform allows for testing millions of correctly paired fully natural IgGs from humans and mice for therapeutic effects, rather than just for binding. Rare functional hits are readily identified, which might be laborious or even impossible using other technologies. Velabs’ antibody screens can thus significantly and competitively shorten pre-clinical development.
3M EUR
$1M to $10M
Heidelberg, Baden-Wurttemberg, Germany
2017-01-01
info(AT)velabs-therapeutics.com
Christine Köhler, Christoph Antz, Christoph Merten, Edward Lemke
11-50
2019-06-27
Private
© 2025 bioDAO.ai